Contact: firstname.lastname@example.org 617-492-5900
Insights to understand growth and development opportunities to achieve and retain market share, capture customers and improve the top-line.
Enhance your organization’s market position and brand perception through strategies that improve value, create differentiation, and address disruption.
Navigate today's and tomorrow’s competitive marketplace and enhance your strategic decision-making with concrete insights about the external environment.
Expand your company’s marketing reach with data-rich thought leadership research, analysis, data visualization, and report writing services.
It’s one thing to start a business or launch a product, another to earn market share and yet another to […]
Are You Ready for the Restructuring of the Healthcare Industry? Fuld + Company worked with eight regional affiliate payer plans […]
Given the uncertainty surrounding the healthcare industry, stakeholders struggle to develop business strategies that can guide both near- and long-term […]
How Trends in Vertical Integration in Healthcare combined with CVS Health’s Performance-Based Pharmacy Network Demonstrates its Competitive Strategy In March […]
CVS Health’s Strategy includes the creation of Performance-Based Pharmacy Network – What does this mean for healthcare? CVS Health issued […]
This infographic highlights the driver of the healthcare marketplace impacting the payer + provider business landscape. To learn more about our […]
The public conversation about health care in this country may be driven by politics — something we were reminded of last […]
The Wall Street Journal and other sources revealed yesterday that pharmacy operator CVS Health Corporation has made an offer to acquire No. […]
In his article about the current model of capitalism during Aetna CVS merger talks, Clifton Reaf commented: Indeed, the Oracle of Delphi […]
How do you set a business strategy in a highly-regulated market in which you don’t have complete control over what […]
On March 16, 2017, Amgen released positive cardiovascular outcomes data for its PCSK9 inhibitor, Repatha. Yet, it could be tough […]
Last week Aetna announced its intention to acquire Humana for $37 billion in cash and stock. Reasons given for the […]
131 Oliver Street
Boston, MA 02110 USA
+1 617 492 5900
6th Floor, Tower B
+91 (0)120 437 1132
42 Upper Berkeley Street
London, W1H 5PW
+44(0)203 752 6572
2 Kallang Avenue
#06-30 CT Hub
Copyright © 2015, Fuld + Company. All Rights Reserved.
Yelling Mule - Boston Web Design